Top news of June: FAA guidelines, In-N-Out, microaggressions, more
Click Here to Manage Email Alerts
Healio has compiled June’s most-read news in asthma and allergy.
Top stories included a call to change the FAA’s guidelines on airplane medical kits, controversial statements made by the president of In-N-Out Burger, microaggressions in health care, preventing and predicting food allergies, the impact of electronic vapes on asthma and more.
FAA reauthorization act may upgrade airplane medical kits for anaphylaxis
The Federal Aviation Administration Reauthorization Act of 2024 includes a call for updated rules on airplane medical kits and staff training in regard to anaphylaxis-related emergencies. Jason Linde, MA, of Food Allergy Research & Education, explains. Read more.
Allergy specialists react to controversial sesame post by In-N-Out president
Popular fast-food chain In-N-Out Burger announced on June 12 the inclusion of sesame flour in its buns, causing worry for those with an allergy. Company president Lynsi Snyder responded to a concerned consumer with in a controversial social media comment. Zachary E. Rubin, MD, and Niti Chokshi, MD, weigh in on the consequences. Read more.
Early peanut introduction in infancy may prevent allergy in adolescence
Consuming peanut products from infancy through age 5 years provided lasting tolerance into adolescence without the need to regularly upkeep consumption, according to a study published in NEJM Evidence. Patricia Fulkerson, MD, PhD, comments on the results. Read more.
‘Small actions, big impact’: How physicians can identify, respond to microaggressions
Microaggressions are just as commonplace in medical settings as other workplaces, and although they may be small behaviors, they can have serious impacts on employee morale and patient care when they go unaddressed, Nancy I. Joseph, DO, FACAAI, said in our Women in Allergy series Read more.
Metformin associated with fewer hospitalizations in children with asthma
Children with asthma who used metformin experienced decreases in asthma-related hospitalizations and oral steroid use, according to an abstract presented by Erhan Ararat, MD, at the annual American Thoracic Society International Conference. Read more.
Panel OKs vaccination during dupilumab treatment
Vaccinations can be safe and effective during dupilumab treatment, according to the consensus of a panel published in Annals of Allergy, Asthma & Immunology. But these vaccinations should proceed only after physicians and patients have shared in the decision-making, Jay A. Lieberman, MD, of the University of Tennessee Health Science Center, told Healio. Read more.
Q&A: Allergy test interpretations require caution
Allergy treatment relies on accurate diagnoses, but current methods such as skin, blood and provocation testing all offer limitations that can lead to false positives and other poor outcomes, Rasa Petraityt-Burneikien, PhD, research scientist at Vilnius University Life Sciences Centre, said in our exclusive interview. Read more.
Electronic nicotine delivery systems linked to higher risk for earlier asthma onset
The use of electronic nicotine delivery systems by adults in the last 30 days was associated with earlier ages of asthma onset, suggesting that public health measures should be taken to motivate users to stop, Adriana Pérez, PhD, professor of biostatistics and data science at UTHealth Houston School of Public Health, told Healio. Read more.
Commonality of child food allergies highlight importance of prevention and treatment
Allergic disease affects 40% of school-aged children in Australia, and 45% of food allergies among infants persist until age 10 years. “Understanding how many children are affected by allergies is important for informing public health and research priorities,” Rachel L. Peters, PhD, associate professor at Murdoch Children’s Research Institute, told Healio. Read more.
Q&A: How to use ‘buy and bill’ for biologic treatment in allergy, asthma care
As biologics become more popular for a growing number of indications, practices need to figure out the most cost-effective ways to provide these treatments to their patients.Many practices are now using “buy and bill” to offer biologic care, according to Priya J. Bansal, MD,FAAAAI, FACAAI, past chair of the American Academy, of Allergy, Asthma & Immunology Practice Management Committee and Workshop and Healio Asthma and Allergy Peer Perspective Board Member. Read more.